In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EA1/174/05, NCT00168987

2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904

3.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NKP_CA_04, NCT01596933

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: S0927, U10CA037429, SWOG-S0927, NCT01385137

6.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2009P-001217, NCT01169259

7.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065766, CLB-9473, NCI-P97-0097, CALGB-9473, NCT00003077

8.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 90
Sponsor: NCCAM
Protocol IDs: P50 AT000437, JHM - IRB # 03-02-10-12, NCT00094562

9.

Phase: Phase II
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007DR2232, 1345 (institution), 120/07 (ethics review board), NCT00533078

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 10097, REC reference: 06/Q2501/160, EudraCT number: 2006-000044-71, NCT00942292

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09/H0408/51, EudraCT number 2009-009470027, UHL trial number 10720, NCT01019382

12.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NEDH-91062786, NCI-P92-0019

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10024, NCI-2012-02933, NCT01282580

14.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-HSPC-9508339, NCI-V96-0940

15.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CSMC-00006359, CSMC-00000509, NCT00114296

16.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000443617, P30CA069533, OHSU-CI-CPC-04131-LX, VAMC-04-0303/ M1016, DOD-W81XWH-04-1-0296, OHSU-1117, KPNW-NW-05SLIEB-01, VAMC-04-0303, DOD-A-12538, OHSU-KPNW-NW-05SLIEB-01, NCT00253643

17.

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: IFR02/2004, NCT00145015

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000505501, UCSF-03553, UCSF-H5664-22834-04A, NCT00402285

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 21
Sponsor: NCI, Other
Protocol IDs: CDR0000581419, P30CA069533, OHSU-3872, OHSU-CTRC-1037, 3872, NCT00627276

20.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 35 to 70
Sponsor: Other
Protocol IDs: 26970, NCT00723398

21.

Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis
Status: Closed
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 01-07-026, P50 CA 92131-01A1, NCT00798876

22.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 01-07-026-21, P50CA092131-01A1, NCT00836615

23.

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AICR 08-0131, UKCRN 6873, NCT01032343

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 70
Sponsor: Other
Protocol IDs: PHO-0702, NCT01127867

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-11022, NCI-2011-03262, NCT01478477
1   
New Search